Skip to content

A clinical trial to compare three ultrasound guided therapies for management of patients with carpal tunnel syndrome

Ultrasound guided therapeutic interventional techniques in carpal tunnel syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/12/016604
Enrollment
60
Registered
2018-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G560- Carpal tunnel syndrome

Interventions

Intervention1: normal saline: 5 to 10 cc of normal saline (hydrodissection fluid) Intervention2: corticosteroid plus normal saline: 7 to 10 cc of hydrodissection fluid comprising of 2ml injectate (1ml

Sponsors

University College of medical sciences and Guru Teg Bahadur hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18 years and above having Nerve Conduction Studies proven carpal tunnel syndrome with persistent symptoms and not resolving with medications or splinting

Exclusion criteria

Exclusion criteria: 1. Patients with other neurological causes like polyneuropathies, thoracic outlet syndrome, cervical radiculopathy 2. Patients with underlying coagulopathies or taking anti-coagulant medications 3. Patients in whom ultrasound will reveal secondary causes of carpal tunnel syndrome like Ganglion cysts, accessory muscles etc 4. Patients with local site infection 5. Patients who have received prior corticosteroid injection or hav undergone carpal tunnel release surgery 6. Patients with thenar atrophy

Design outcomes

Primary

MeasureTime frame
Change from baseline of: 1.Severity of symptoms and functional status using Boston Carpal Tunnel Syndrome Questionnaire Questionnaire. 2.Pain using Visual Analogue Scale (VAS). 3.Cross-sectional area of the median nerve using ultrasound. 4.Conduction velocity and amplitude of median nerve as and when applicable.Timepoint: 4,12 weeks and 24 weeks (when feasible) post procedure

Secondary

MeasureTime frame
noneTimepoint: none

Countries

India

Contacts

Public ContactAnupama Tandon

University college of medical sciences and GTB Hospital

anupamatandon@hotmail.com8585977903

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026